The company is recognized for its innovation, scientific expertise, and customer-centric clinical development model in the global biotechnology CRO market SAN ANTONIO, May 12, 2026 /PRNewswire/ ...

U.S. Food and Drug Administration (FDA) review of oxylanthanum carbonate (OLC) New Drug Application (NDA) resubmission remains on track, with a Prescription Drug User Fee Act (PDUFA) target action dat ...

Over 315 patients screened and over 230 patients enrolled in BriaCell’s pivotal Phase 3 Bria-ABC study of Bria-IMT plus immune checkpoint inhibitor in metastatic breast cancer Enrollment momentum ...

NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company), a global biotechnology platform company committed to ...

Company closed PIPE financing with gross proceeds of up to $175 million, including the possible exercise of warrants, from ...

In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA, 3,588 patients initiated treatment, and ~5,400 prescriptions were filled Agreement signed in May with leading grou ...

SkylineDx, an innovative company specializing in molecular diagnostics for dermatology, today announced data from two oral and one ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial ...

Completed transformative acquisition of PXL-770, (now SCY-770), an innovative, highly selective, direct AMPK activator for the treatment of ...

Announced strategic collaboration with Mayo Clinic, focused on improving care in type 1 diabetes and accelerating development of SC451Continued ...

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry ...

From Genryo’s Sidewinder technology to the Festival of Genomics & Biodata in the UK earlier this year – AI might be trending, ...